COLITIS, ULCERATIVE
Clinical trials for COLITIS, ULCERATIVE explained in plain language.
Never miss a new study
Get alerted when new COLITIS, ULCERATIVE trials appear
Sign up with your email to follow new studies for COLITIS, ULCERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ulcerative colitis sufferers: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug, JNJ-78934804, against an existing treatment (guselkumab) in 644 people with moderate to severe ulcerative colitis, a chronic condition causing colon inflammation and ulcers. The goal is to see if the new drug can safely bring about remission (no sympt…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
New drug balinatunfib tested for long-term safety in inflammatory bowel disease
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called balinatunfib in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year study with the drug or a placebo. The goal is to see if the drug is safe over a longer period, up to about t…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Good viruses may hold key to taming IBD
Knowledge-focused Not yet recruitingThis study looks at the role of viruses (bacteriophages) in the gut of people with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Researchers will collect stool and blood samples from 30 patients and 10 healthy donors to understand differences…
Matched conditions: COLITIS, ULCERATIVE
Sponsor: Andreas Munk Petersen • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Real-World study tracks guselkumab use in IBD patients
Knowledge-focused Not yet recruitingThis study watches 50 adults with moderate-to-severe Crohn's disease or ulcerative colitis who are already starting guselkumab as part of their normal care. Researchers will track how long patients continue the drug and how they respond early on. No extra treatments or changes ar…
Matched conditions: COLITIS, ULCERATIVE
Sponsor: Janssen-Cilag A.G., Switzerland • Aim: Knowledge-focused
Last updated May 26, 2026 02:46 UTC